Skip to content
Immunotherapy for Squamous Non-Small Cell Lung Cancer episode artwork

Jun 11, 2015 8 min

Immunotherapy for Squamous Non-Small Cell Lung Cancer

from GRACEcast Hosted by cancerGRACE Meetings

Research released at the 2015 American Society of Clinical Oncology (ASCO) annual meeting showed great promise for squamous cell lung cancer patients taking the immunotherapy drug Opdivo (nivolumab). But can we predict which patients will do well on it?

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Immunotherapy for Squamous Non-Small Cell Lung Cancer

0:00 8:00

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of GRACEcast?

This episode is 8 minutes long.

When was this GRACEcast episode published?

This episode was published on June 11, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.